Catheter Precision Inc (AMEX:VTAK) currently has a daily average trading volume of 546.88K but it saw 1121787 shares traded in last market. With a market cap of 2.22M USD, the company’s current market price of $0.20 came rising about 2.55 while comparing to the previous closing price of $0.20. In past 52 weeks, the stock remained buoying in the range of price level as high as $8.40 and as low as $0.16.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Piper Jaffray which downgraded the stock as “Neutral” in its note to investors issued on August 13, 2019, recommending a price target of between $9 and $1.50 for it.
Over the week, VTAK’s stock price is moving 7.65% up while it is -27.34% when we observe its performance for the past one month. Year-to-date it is -55.39% down and over the past year, the stock is showing a downside performance of -95.98%.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Catheter Precision Inc’s total number of outstanding shares is 11.02M with 7.31% of that held by the insiders while 5.34% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -126.65% and return on equity (ROE) at -136.26%. Stock’s beta reads -0.86. Stock has a price to book (P/B) ratio of 0.24 while price to sale or P/S ratio amounts to 4.63. Its return on asset (ROA) is -68.20% on average.
